£82.04

It has never been this cheap. We have no record of a lower price.

£82 today · cheaper than every other day in the last 3 months

Springer Immunodiagnosis and Immunotherapy of Malignant Tumors: Relevance to Surgery

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£89.40 £81.30 £83.07 £84.84 £86.60 £88.37 £90.14 25 July 2026 09 August 2026 24 August 2026 08 September 2026 24 September 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 3 price levels

Days at Price
Current Price
14 days · current 34 days 14 days 0 9 17 26 34 £82 £88 £89 Days at Price

Price Analysis

Most common price: £88 (34 days, 54.8%)

Price range: £82 - £89

Price levels: 3 different prices over 62 days

Description

The concept of immunologic responses against tumors is currently under intense scrutiny throughout the world. The evidence for the existence of tumor-specific transplantation antigens (TSTA) and specific immune reactions to them in experimental animals is overwhelming. The available data concerning human tumors are controversial. The reason for this is partially that antigens detectable on human tumors by in vitro assays have not been biologically characterized. In other words, we do not know if the antigens on human tumors are acting as the targets for immunologically mediated rejection processes in vivo. It was the purpose of this workshop to bring experimental tumor immunologists and clinical oncologists together in order to disclose facts and limits in tumor immunology. Clinicians were to learn how shaky the ground becomes once the experimentalist looks beyond the edge of the mouse cage. Tumor biologists heard the clinicians' urgent cry for controlled randomized trials of immunotherapy which thus reflects clearly that immunotherapy in its present form without knowledge of dose-effect-relationship does not work. Nobody would deny that the problem of human cancer smells of immunology, but since we are just about to taste it the essential ingredient might be different. In other words one might look at present rather at immunological epiphenomena than at mechanisms of tumor immul1lty operating in vivo. This problem was among others a central issue of this workshop.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
15 March 1979
Listed Since
21 February 2011

Barcode

No barcode data available

Similar Products You Might Like

Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)
98% match

Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)

CRC Press

£79.41 23 Sep 2026
Immunotherapy of Cancer: Innovative Treatment Comes of Age
98% match

Immunotherapy of Cancer: Innovative Treatment Comes of Age

Springer

£106.33 02 Oct 2026
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
97% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 01 Oct 2026
Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)
97% match

Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)

Springer

£143.27 24 Sep 2026
Cancer Immunotherapy (Advances in Immunology): Volume 90
97% match

Cancer Immunotherapy (Advances in Immunology): Volume 90

Elsevier

£132.29 26 Sep 2026
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
97% match

Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)

CRC Press

£170.01 23 Sep 2026
Critical Developments in Cancer Immunotherapy
97% match

Critical Developments in Cancer Immunotherapy

£421.00 01 Oct 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
97% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£74.21 23 Sep 2026
Immunotherapy of Cancer (Cancer Drug Discovery and Development)
97% match

Immunotherapy of Cancer (Cancer Drug Discovery and Development)

Humana

£70.98 24 Sep 2026
Novel Immunotherapeutic Approaches to Cancer Treatment - Springer
97% match

Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Springer

£114.88 02 Oct 2026
Novel Immunotherapeutic Approaches to Cancer Treatment - Springer
97% match

Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Springer

£108.91 03 Oct 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
97% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Springer

£158.93 30 Sep 2026
Immunotherapy for Solid Malignancies, An Issue of Surgical Oncology Clinics of North America (Volume 28-3) (The Clinics: Surgery, Volume 28-3)
97% match

Immunotherapy for Solid Malignancies, An Issue of Surgical Oncology Clinics of North America (Volume 28-3) (The Clinics: Surgery, Volume 28-3)

Elsevier

£81.99 30 Sep 2026
Cancer and Autoimmunity (Autoanitbody Library)
97% match

Cancer and Autoimmunity (Autoanitbody Library)

Elsevier

£87.68 24 Sep 2026
Tumor Immunology and Cancer Therapy - CRC Press
97% match

Tumor Immunology and Cancer Therapy - CRC Press

CRC Press

£116.38 24 Sep 2026